Insights: DrugPatentWatch - Find Your Next Blockbuster

Insights: DrugPatentWatch - Find Your Next Blockbuster

By DrugPatentWatchBusiness
Download on the App Store

Insights: DrugPatentWatch - Find Your Next Blockbuster episodes

  • New patent for Dow Pharm drug ACANYA
    Annual Drug Patent Expirations for ACANYA Acanya is a drug marketed by Dow Pharm and is included in one NDA. It is available from three suppliers. There are four patents…
    The post New patent for Dow Pharm drug ACANYA appeared first on DrugPatentWatch - Make Better Decisions.
    0 min
  • New patent expiration for Glaxosmithkline drug VENTOLIN HFA
    Annual Drug Patent Expirations for VENTOLIN+HFA Ventolin Hfa is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from fourteen suppliers. There are fifteen patents…
    The post New patent expiration for Glaxosmithkline drug VENTOLIN HFA appeared first on DrugPatentWatch - Make Better Decisions.
    0 min
  • New patent for Ucb Inc drug NEUPRO
    Annual Drug Patent Expirations for NEUPRO Neupro is a drug marketed by Ucb Inc and is included in one NDA. It is available from one supplier. There are seven patents…
    The post New patent for Ucb Inc drug NEUPRO appeared first on DrugPatentWatch - Make Better Decisions.
    0 min
  • New patent for Purdue Pharma drug HYSINGLA
    Annual Drug Patent Expirations for HYSINGLA Hysingla is a drug marketed by Purdue Pharma Lp and is included in one NDA. It is available from one supplier. There are thirty-six…
    The post New patent for Purdue Pharma drug HYSINGLA appeared first on DrugPatentWatch - Make Better Decisions.
    0 min
  • Drug Repositioning: Concept, Classification, Methodology, and Importance in Rare/Orphans and Neglected Diseases
    This paper was originally published by Emanuel Almeida Moreira de Oliveira and Karen Luise Lang in Journal of Applied Pharmaceutical Science Vol. 8(08), pp 157-165, August, 2018 under the terms of the…
    The post Drug Repositioning: Concept, Classification, Methodology, and Importance in Rare/Orphans and Neglected Diseases appeared first on DrugPatentWatch - Make Better Decisions.
    0 min
  • Which pharmaceutical companies have the most SPCs in Switzerland?
    This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Switzerland. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
    The post Which pharmaceutical companies have the most SPCs in Switzerland? appeared first on DrugPatentWatch - Make Better Decisions.
    0 min

About Insights: DrugPatentWatch - Find Your Next Blockbuster

From the publisher's feed

Business Intelligence on Biologic and Small Molecule Drugs from DrugPatentWatch.com

More shows like Insights: DrugPatentWatch - Find Your Next Blockbuster

All-In with Chamath, Jason, Sacks & Friedberg by All-In Podcast, LLC

All-In with Chamath, Jason, Sacks & Friedberg

10,184 Listeners